client-letter-investor-communication.docx

1023-00002 · Ironside Capital Management LP · Client Correspondence

client-letter-investor-communication.docx DOCUMENT Litigation

1 / 35 → ✕

CALDERWOOD & HARKNESS LLP 51 West 52nd Street, 40th Floor New York, NY 10019 Telephone: (212) 556-4000 Facsimile: (212) 556-4001 www.calderwoodharkness.com

November 20, 2023

Via Email and Hand Delivery

PRIVILEGED AND CONFIDENTIAL — ATTORNEY-CLIENT COMMUNICATION / ATTORNEY WORK PRODUCT

Katherine Lim, Esq. General Counsel & Chief Compliance Officer Ironside Capital Management LP 680 Park Avenue, 34th Floor New York, NY 10065

Re: Investor Communication Considerations — Disclosure Obligations to Limited Partners Arising from Vantor Holdings Corp. Fund Administration Misvaluation

From: Samuel Eklund, Responsible Partner, Calderwood & Harkness LLP

cc: Elliot Brennan, Co-Founder, Managing Partner & Chief Investment Officer, Ironside Capital Management LP Marguerite Dao, Co-Founder, President & Chief Operating Officer, Ironside Capital Management LP Rajiv Subramanian, Chief Financial Officer, Ironside Capital Management LP Linda Osei, Billing Partner, Calderwood & Harkness LLP

Dear Katherine:

We write in connection with our engagement as litigation counsel to Ironside Capital Management LP ("Ironside" or the "Firm") to provide guidance on Ironside's disclosure obligations to the limited partners ("LPs") of its three feeder funds in light of the systematic misvaluation of fund assets by Vantor Holdings Corp. ("Vantor"), Ironside's former fund administrator. This letter is intended to be read in conjunction with our demand letter to Vantor dated November 15, 2023, and the preliminary valuation report delivered by Harmon-Bryce Valuation Advisors LLC on September 22, 2023. The entirety of this letter is protected by the attorney-client privilege and the work product doctrine and should not be disclosed to any third party without the prior written consent of Calderwood & Harkness LLP.

I. Purpose of This Letter

As you are aware, over the course of the past several months, Ironside has uncovered evidence of systematic misvaluation by Vantor Holdings Corp. of illiquid credit and structured-product positions held across Ironside's three feeder fund vehicles: Ironside Credit Opportunities Fund LP ("Fund I"), Ironside Structured Alpha Fund LP ("Fund II"), and Ironside Special Situations Fund LP ("Fund III," and together with Fund I and Fund II, the "Funds"). The misvaluation spans eleven quarters, from the first quarter of 2021 through the third quarter of 2023, and has resulted in an aggregate overvaluation of approximately $287 million. The implications for Ironside's limited partners — and for Ironside itself — are significant and far-reaching.

The purpose of this letter is to provide Ironside's in-house legal and compliance team with guidance regarding the Firm's obligations to disclose the Vantor misvaluation to the limited partners of the three affected Funds. Specifically, we address: (a) the legal framework governing LP disclosure obligations, including the applicable provisions of the limited partnership agreements, federal securities laws, and the Investment Advisers Act of 1940; (b) the identification of key investors requiring special attention; (c) our recommended disclosure approach and timeline; (d) suggested parameters for the content of the investor notice, including both what to include and what to exclude in order to protect litigation strategy and attorney-client privilege; and (e) certain risk considerations that should inform Ironside's approach.

By way of procedural context, we note the following significant recent developments:

• Ironside terminated the Master Fund Administration Agreement with Vantor (the "FAA," dated June 15, 2017; Reference No. VHC-ICM-2017-0615) for cause on October 3, 2023, pursuant to Section 12.2 of the FAA, following the completion of an initial internal investigation and the receipt of independent valuation analysis confirming material overvaluation across all three Funds.

• Ironside transitioned fund administration functions to Meridian Investor Services LLC ("Meridian"), under the direction of Meridian's Chief Executive Officer, Anne-Claire Dupont, effective October 10, 2023. The transition was completed on an expedited basis and Meridian has assumed responsibility for all ongoing NAV calculations, capital account recordkeeping, and investor reporting.

• Calderwood & Harkness transmitted a formal demand letter to Vantor on November 15, 2023, setting forth the factual basis for Ironside's claims and demanding, among other things, full restitution of all damages arising from the misvaluation. The investor communication analysis set forth in this letter runs in parallel with our pre-litigation demand process and will be coordinated to ensure consistency between the two.

We wish to emphasize that this letter is advisory in nature. Ironside's in-house legal and compliance team, under your leadership, will ultimately bear responsibility for managing regulatory filings and investor communications. Calderwood & Harkness's role is limited to providing litigation counsel guidance — specifically, to ensure that investor-facing communications are consistent with the factual narrative underlying our litigation strategy, do not inadvertently waive privilege or work product protections, and do not contain statements that could be used adversely by Vantor or other parties in subsequent proceedings. We are not opining on matters of Delaware partnership law, securities regulation compliance, or tax, and we encourage you to engage specialized counsel as needed on those matters.

II. Background Summary for Context

We provide the following factual summary for context. This summary draws on the preliminary report of Harmon-Bryce Valuation Advisors LLC and on the internal findings of Ironside's finance and operations teams. It is not intended to be exhaustive; rather, it is designed to frame the disclosure analysis that follows.

A. Discovery and Independent Valuation

In July 2023, Rajiv Subramanian, Ironside's Chief Financial Officer, identified a discrepancy of approximately $12.6 million across seven CLO equity positions when he compared Vantor's marks to independent pricing indications provided by Northpoint Securities. Mr. Subramanian escalated the discrepancy to you and to the Firm's senior leadership, and Ironside promptly engaged Harmon-Bryce Valuation Advisors LLC ("Harmon-Bryce"), an independent valuation firm led by Dr. Lena Galbraith, CFA, ASA, to conduct a comprehensive review of all illiquid credit and structured-product positions across the three Funds.

Harmon-Bryce delivered its preliminary report on September 22, 2023 (Reference No. HBVA-2023-0922-IRON). The report identified forty-seven (47) mispriced illiquid positions across the three Funds, spanning CLO equity tranches, bespoke CDO mezzanine notes, and distressed loan participations. The misvaluation was systematic in nature and persisted over eleven consecutive quarters.

B. Magnitude of the Overvaluation

The aggregate overvaluation identified by Harmon-Bryce is as follows:

The average mark inflation across the affected positions was approximately 14.3% above observable inputs. The overvaluation of NAV per unit ranged from approximately 3.8% in the first quarter of 2021 — the earliest affected period — to a peak of approximately 8.6% in the fourth quarter of 2022. The single-quarter overvaluation reached its maximum of approximately $52.3 million in the fourth quarter of 2022, coinciding with a period of significant dislocation in credit markets and wider bid-ask spreads in the affected asset classes.

C. Consequences of the Misvaluation

The misvaluation has produced a number of concrete adverse consequences for Ironside and its limited partners, which we summarize as follows:

Overpayments to Redeeming LPs. During the eleven-quarter misvaluation period, Ironside processed 217 investor redemptions at inflated NAV, resulting in aggregate overpayments to redeeming limited partners of approximately $43.2 million. These overpayments were funded from the remaining assets of the Funds, thereby diluting the interests of non-redeeming limited partners.

Excess Management Fees. Ironside collects a management fee at an annual rate of 1.5% of net asset value. Because NAV was overstated during the misvaluation period, Ironside collected excess management fees of approximately $4.3 million. Ironside has offered to disgorge these amounts in full, a decision that we commend as both ethically appropriate and strategically valuable in mitigating LP claims and regulatory exposure.

Inflated Performance Allocations. The Funds' performance allocation is calculated at a rate of 20% of net profits above a 6% annualized hurdle rate. To the extent that the inflated NAV figures caused the performance allocation to be calculated on overstated returns, the general partner may have received performance allocations to which it was not entitled. The precise quantum of excess performance allocations is being calculated by Meridian Investor Services in coordination with Harmon-Bryce and will be included in the restated capital account statements.

Misstated Capital Account Balances. Both subscribing and redeeming investors received capital account statements reflecting inflated balances. Subscribing investors who entered the Funds during the misvaluation period may have acquired interests at prices above true NAV, while redeeming investors received proceeds in excess of their true entitlements. The resulting misallocation of value among limited partners will need to be addressed through the restatement process.

Misstated Regulatory Filings. Ironside's regulatory filings during the misvaluation period, including Form PF (filed with the SEC on a quarterly basis) and Form ADV (updated annually and as required upon the occurrence of material events), contained NAV figures and position-level data derived from Vantor's inflated valuations. These filings will need to be corrected.

Audit Implications. Ironside's independent auditor, Claremont & Strauss LLP, under the direction of audit partner Howard Stein, issued unqualified audit opinions on the financial statements of the three Funds for the fiscal years ended December 31, 2021 and December 31, 2022. To the extent that the misvaluation was material to those financial statements, restatement may be required. We understand that Katherine Lim will coordinate directly with Mr. Stein regarding the audit restatement timeline.

Pending LP Arbitrations. Three limited partners have initiated arbitration proceedings against Ironside, alleging damages arising from the misvaluation. We understand that the estimated defense costs for these three proceedings are approximately $6.1 million. These arbitrations underscore the urgency of proactive investor communication to limit the risk of additional claims.

III. Legal Framework for LP Disclosure Obligations

This section analyzes the principal sources of law and contractual obligation that govern Ironside's duty to disclose the Vantor misvaluation to its limited partners. As noted above, our analysis is informed by our litigation-counsel perspective and is not intended to substitute for a comprehensive securities regulation or partnership law opinion.

A. Limited Partnership Agreement Provisions

Each of the three Fund limited partnership agreements (the "LPAs") contains provisions relating to investor notification upon the occurrence of material events, changes to NAV methodology or NAV calculations, and the initiation of litigation or arbitration proceedings involving the Fund. Although we have not yet completed our review of the LPAs — we have requested that you provide Calderwood & Harkness with copies of all three Fund LPAs, along with any side letter agreements — the disclosure provisions in fund limited partnership agreements of this type typically require the general partner to provide prompt written notice to limited partners of any event that would materially affect the computation of NAV or the determination of capital account balances.

The discovery of a $287 million aggregate overvaluation, spanning eleven quarters and affecting forty-seven positions across three Funds, is unquestionably material under any reasonable interpretation of the LPA notification provisions. The overvaluation resulted in NAV per unit being overstated by as much as 8.6% in a single quarter. It affected both subscribing and redeeming investors. It resulted in $43.2 million in overpayments. Under these circumstances, we believe it is beyond serious dispute that the LPAs require prompt written notice to the limited partners.

We recommend that Ironside's in-house team conduct a detailed review of the specific notification provisions in each of the three LPAs, including any differences among the Funds in the scope or timing of required disclosures. In addition, any side letter agreements that grant particular limited partners enhanced information rights, inspection rights, or reporting rights should be identified and reviewed. We understand that Ashford Endowment Partners LP, in particular, may hold side letter rights that expand upon the baseline LPA disclosure obligations.

More broadly, we note that the general partner of each Fund owes a duty of good faith and fair dealing to the limited partners under the Delaware Revised Uniform Limited Partnership Act ("DRULPA"), 6 Del. C. § 17-1101(d). While the LPAs may modify or limit certain default fiduciary duties — as is common in Delaware limited partnerships — the implied covenant of good faith and fair dealing cannot be eliminated by contract. A failure to disclose a known and material misvaluation of fund assets could be challenged by limited partners as a breach of this covenant, particularly where the general partner has actual knowledge of the overvaluation and the means to correct it.

B. Regulation D Obligations

The offerings of interests in the three Funds were conducted pursuant to Regulation D under the Securities Act of 1933 (the "Securities Act"), relying on the exemption from registration provided by Rule 506(b) or Rule 506(c), as applicable. Regulation D does not, by its own terms, impose a standalone ongoing disclosure obligation on issuers following the completion of an offering. However, the anti-fraud provisions of the federal securities laws apply with full force to all offerings, whether registered or exempt, and those provisions impose affirmative duties in the circumstances present here.

Specifically, Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder prohibit any person from making any untrue statement of a material fact, or omitting to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, in connection with the purchase or sale of any security. Similarly, Section 17(a) of the Securities Act prohibits the use of any device, scheme, or artifice to defraud, or any untrue statement or omission of a material fact, in the offer or sale of securities.

To the extent that any limited partner is currently in the process of subscribing to one of the Funds — or has recently subscribed — based on NAV figures or capital account balances that were materially inflated by Vantor's misvaluation, the failure to disclose the overvaluation could give rise to liability under these anti-fraud provisions. The materiality of the overvaluation is not in doubt: an aggregate misstatement of $287 million, with single-quarter overvaluation as high as $52.3 million and NAV per unit inflation as high as 8.6%, would plainly be considered material by a reasonable investor.

Furthermore, any capital account statements, quarterly NAV reports, investor letters, or other communications distributed to limited partners during the Q1 2021 through Q3 2023 period that contained NAV figures derived from Vantor's inflated valuations were, in retrospect, materially misleading. While those communications were not intentionally misleading by Ironside — the misvaluation originated with Vantor — Ironside now has actual knowledge that the information was incorrect. Under these circumstances, the anti-fraud provisions require Ironside to take reasonable steps to correct the record. Continued silence, once Ironside is aware of the misstatement, could transform what was initially an innocent misrepresentation into a potentially actionable omission.

C. Investment Advisers Act of 1940 — Fiduciary Duties

Ironside is registered with the Securities and Exchange Commission as an investment adviser (SEC CRD No. 158742; SEC File No. 801-79534). As a registered investment adviser, Ironside owes fiduciary duties to its fund clients and, by extension, to the limited partners who are the beneficial owners of the fund assets. These fiduciary duties have been recognized by the Supreme Court in SEC v. Capital Gains Research Bureau, Inc., 375 U.S. 180 (1963), and are the cornerstone of the regulatory framework governing investment advisers.

The fiduciary duties of an investment adviser include, among other things, the obligation to disclose all material facts and conflicts of interest to clients. The SEC has consistently taken the position that an adviser's fiduciary duty encompasses a duty of full and fair disclosure — that is, an affirmative obligation to provide clients with all information material to the advisory relationship, including information relating to the valuation of client assets.

The Vantor misvaluation is, by any measure, a material fact that must be disclosed to the limited partners. The overvaluation directly affects the value of each limited partner's investment, the accuracy of historical performance figures, the reliability of NAV-based reporting, and the fairness of past redemptions and subscriptions. A failure to disclose the misvaluation — particularly now that Ironside has actual knowledge of it — could be characterized by regulators or litigants as a breach of Ironside's fiduciary duty. This is so notwithstanding the fact that the misvaluation originated with Vantor rather than with Ironside itself. An investment adviser's fiduciary duty does not permit it to remain silent once it becomes aware that the information it has provided to clients is materially inaccurate.

We also note the overlap between these fiduciary duties and Ironside's obligations under Form ADV Part 2A (the "brochure"), which requires the adviser to describe material risks and conflicts of interest. While the brochure is typically updated on an annual basis, material changes must be communicated to clients promptly through an amended brochure or a summary of material changes.

D. Form ADV Item 11 and Form PF

Turning to specific regulatory filing obligations, we note two areas of immediate concern.

Form ADV Item 11. Item 11 of Form ADV Part 1A requires the adviser to disclose certain disciplinary and legal events, including pending or concluded legal proceedings that are material to an evaluation of the adviser's integrity or ability to meet contractual commitments to clients. The anticipated litigation against Vantor — which we intend to initiate following the expiration of the demand period — and the three pending LP arbitrations likely trigger the Item 11 disclosure obligation. Ironside should assess whether the filing of a Form ADV amendment is required and, if so, should prepare the amendment promptly.

Form PF. Form PF requires large private fund advisers to report, on a quarterly basis, certain information about the private funds they manage, including NAV, gross and net asset values, borrowings, and investor concentration data. To the extent that Ironside's prior Form PF filings contained NAV figures and position-level data derived from Vantor's inflated valuations, amendments to those filings may be required.

We wish to note explicitly that regulatory filings are outside the scope of Calderwood & Harkness's litigation-focused engagement. The preparation and filing of amendments to Form ADV and Form PF will be handled by Katherine Lim and Ironside's in-house legal and compliance team. However, because statements in regulatory filings could be used by Vantor or other adverse parties in litigation, we request the opportunity to review draft disclosures for consistency with the factual narrative underlying our litigation positions before those filings are submitted. This is a narrow review focused solely on litigation-consistency and privilege issues; it does not expand the scope of our engagement.

Finally, we recommend that Ironside coordinate with Claremont & Strauss LLP, and specifically with audit partner Howard Stein, regarding the audit implications of the misvaluation. If the aggregate overvaluation is material to the audited financial statements for fiscal years 2021 and 2022, restated financial statements may be required, and the timing of any restatement should be coordinated with the investor notification process described in Section V below.

IV. Key Investors Requiring Special Attention

While all limited partners of the three Funds are entitled to receive notice of the Vantor misvaluation, certain investors warrant individualized attention due to the size of their commitments, their contractual rights, or the particular impact of the misvaluation on their capital accounts.

A. Ashford Endowment Partners LP

Ashford Endowment Partners LP ("Ashford") is the lead limited partner across the three Funds, with aggregate committed capital of approximately $340 million. Ashford's principal contact is Philip Ashford III, Managing Director, and its offices are located at 55 Church Street, Suite 800, New Haven, Connecticut 06510.

As the largest investor in the Funds, Ashford's capital account balances have been materially misstated for each of the eleven quarters during which the misvaluation persisted. The dollar magnitude of the overstatement attributable to Ashford's accounts — which, given Ashford's proportionate share of total fund assets, may be in the range of tens of millions of dollars — is significant by any measure.

Moreover, Ashford's position as lead LP is likely accompanied by a suite of enhanced contractual rights. Based on our experience with fund structures of this type, and subject to our review of the actual side letter agreements, we anticipate that Ashford may hold most-favored-nation ("MFN") side letter provisions, enhanced information and transparency rights (potentially including the right to receive position-level reporting, portfolio analytics, or risk metrics on a more frequent basis than other LPs), advisory committee membership, and enhanced audit or inspection rights that could entitle Ashford to more detailed disclosure than the general LP population. Each of these rights should be identified and assessed to ensure that the disclosure provided to Ashford satisfies any heightened obligations.

Given the size of Ashford's commitment and the likely breadth of its contractual rights, we strongly recommend individualized communication with Ashford in advance of the general LP notice. This communication should take the form of a direct telephone call or in-person meeting between Ashford's leadership and Ironside's senior management — ideally Elliot Brennan and/or Marguerite Dao — followed by a detailed written communication tailored to Ashford's specific accounts and contractual entitlements. The purpose of this individualized outreach is twofold: first, to fulfill any enhanced disclosure obligations that Ashford's side letters may impose; and second, to demonstrate Ironside's commitment to transparency and proactive engagement, thereby mitigating the risk that Ashford will join or initiate LP arbitration proceedings. As noted above, three LP arbitrations are already pending, and the addition of a claimant of Ashford's size and sophistication would materially increase both the stakes and the cost of those proceedings.

B. Other Institutional and Significant LPs

Beyond Ashford, we recommend that Ironside identify all limited partners with committed capital above a defined threshold — we suggest $50 million as the initial threshold, to be adjusted based on the actual LP roster — for priority outreach. These investors are likely to include institutional allocators such as pension funds, endowments, foundations, insurance companies, and fund-of-funds vehicles, many of which will have their own reporting, disclosure, and governance obligations that are triggered by the misvaluation. Providing these investors with advance notice (or, at a minimum, contemporaneous notice accompanied by a higher level of detail) will serve both Ironside's legal obligations and its business interests.

In addition, the 217 limited partners who redeemed their interests during the misvaluation period — and who collectively received overpayments totaling approximately $43.2 million — will require specific communications addressing the NAV restatement and the potential mechanisms for addressing those overpayments. The communication to redeeming LPs should explain the basis for the restatement, quantify the estimated overpayment attributable to each redeemer's specific redemption, and describe the process by which Ironside intends to address the overpayments, whether through clawback, offset against future distributions, or negotiated resolution. The legal authority for clawback or offset will depend on the specific provisions of the applicable LPA and any side letter, and we recommend that Ironside's in-house team conduct a thorough analysis of those provisions.

V. Recommended Disclosure Approach and Timeline

A. General Principles

Based on our experience in similar matters and our assessment of the legal framework described above, we recommend that Ironside's investor disclosure be guided by the following general principles:

Promptness. Ironside should disclose the misvaluation to its limited partners as promptly as practicable. Delay in disclosure increases Ironside's exposure to claims by limited partners that the Firm failed to meet its fiduciary and contractual obligations, and it erodes the investor confidence that Ironside will need to retain its LP base. Given that Ironside first identified the discrepancy in July 2023 and received the Harmon-Bryce preliminary report in September 2023, the passage of time is already a concern. The goal should be to complete the disclosure process before the end of 2023.

Factual and Measured Tone. The investor notice should be factual, measured, and professional. It should describe the misvaluation in objective terms, acknowledge its impact on the limited partners, and set forth the remedial steps that Ironside has taken and will take. The notice should not contain inflammatory or emotionally charged characterizations of Vantor's conduct. While we believe the evidence supports claims of fraud and intentional misconduct by Vantor, those characterizations belong in the demand letter and the eventual complaint — not in an investor communication. An overwrought or accusatory tone in the investor notice could undermine Ironside's credibility with its LPs and could be characterized by Vantor as prejudicial in the litigation.

Remedial Focus. The notice should emphasize the remedial steps that Ironside has taken, including the termination of Vantor, the retention of Meridian Investor Services as the new fund administrator, the engagement of Harmon-Bryce as an independent valuation firm, and the engagement of independent litigation counsel. This narrative reinforces Ironside's diligence and good faith.

Avoid Speculation. The notice should not speculate on the ultimate amount of damages that Ironside or its LPs may recover from Vantor, the likely timeline or outcome of litigation, or any other contingent matter. Speculative statements create expectations that may not be fulfilled and could be used adversely in subsequent proceedings.

Privilege Protection. The investor notice itself should not disclose the substance of any attorney-client communications between Ironside and Calderwood & Harkness, or any attorney work product (including the detailed analysis in the Harmon-Bryce report, the Kessler analysis, or the strategic assessments contained in this letter and other Calderwood & Harkness correspondence). The notice should reference the retention of counsel only in general terms — e.g., "Ironside has engaged independent legal counsel to pursue all available remedies against Vantor" — without identifying Calderwood & Harkness by name, disclosing the specific theories of liability, or revealing any aspect of the litigation strategy.

B. Recommended Sequence

We recommend that Ironside proceed in the following sequence:

Step 1: Internal Preparation (immediate; target completion by end of November 2023). Ironside should finalize the restated NAV figures for each quarter from Q1 2021 through Q3 2023, in coordination with Meridian Investor Services and Harmon-Bryce. Rajiv Subramanian should lead this effort, with support from the relevant teams at Meridian (under the direction of Anne-Claire Dupont) and Harmon-Bryce. Concurrently, Katherine Lim should coordinate with Claremont & Strauss LLP (Howard Stein) to determine whether audited financial statement restatements are required and, if so, the expected timeline for completion. The restated NAV figures and any auditor communications should be finalized before the first investor outreach occurs, so that Ironside is prepared to provide complete and accurate corrected data.

Step 2: Individualized Outreach to Ashford Endowment Partners and Other Major LPs (target: first week of December 2023). Ironside's senior leadership — Elliot Brennan and/or Marguerite Dao — should arrange a telephone call or, if feasible, an in-person meeting with Philip Ashford III at Ashford Endowment Partners to brief Ashford on the misvaluation, the remedial steps taken, and the planned timeline for providing corrected NAV figures and capital account statements. This call or meeting should be followed by a written communication to Ashford that is tailored to Ashford's specific accounts and contractual rights. Similar outreach should be conducted with other significant LPs identified through the prioritization process described in Section IV.B above.

Step 3: General LP Notice (target: mid-December 2023). Following the completion of individualized outreach to major LPs, Ironside should distribute a written notice to all limited partners of the three affected Funds. The notice should include the key elements described in Section VI below, including corrected NAV figures (if finalized by that date), a description of the misvaluation, the remedial steps taken, and contact information for questions. If finalized restated NAV figures are not yet available, the notice should indicate the expected date of delivery and provide preliminary estimates, with appropriate caveats.

Step 4: Follow-Up Capital Account Statements (target: January 2024). Ironside should distribute corrected capital account statements to all current and former limited partners, reflecting restated NAV for each quarter from Q1 2021 through Q3 2023. These statements should clearly identify the original (overstated) figures and the corrected figures for each period, together with explanatory notes describing the basis for the restatement.

Step 5: Regulatory Filings (concurrent with the above steps). Amendments to Form ADV Item 11 and Form PF should be prepared and filed on a timeline consistent with the investor notification process. As discussed in Section III.D, Calderwood & Harkness requests the opportunity to review draft regulatory filings for litigation-consistency purposes prior to submission, but the filing responsibility rests with Ironside's in-house team.

C. Coordination with Litigation Strategy

It is essential that the investor notice be consistent with the factual narrative set forth in our demand letter to Vantor and in the complaint that we anticipate filing if the demand is not satisfied. To that end, we offer the following specific guidance:

The investor notice should not contain any admissions or characterizations that could be used adversely by Vantor in litigation. In particular, the notice should not suggest or imply that Ironside was itself negligent in overseeing Vantor's valuation work. While Vantor can be expected to raise comparative fault or contributory negligence defenses — arguing that Ironside failed to detect the misvaluation sooner — there is no reason for Ironside to provide Vantor with ammunition for those arguments in its own investor communications.

To the contrary, the notice should affirmatively emphasize that Ironside discovered the misvaluation through its own internal controls and monitoring processes. Specifically, the notice should reference (in general terms) that Ironside's Chief Financial Officer identified discrepancies in Vantor's valuations, that Ironside promptly engaged an independent valuation firm to conduct a comprehensive review, and that Ironside acted swiftly upon confirmation of the misvaluation to terminate Vantor, engage a new administrator, and retain litigation counsel. This narrative is not only factually accurate — it directly supports Ironside's litigation position that the misvaluation was attributable to Vantor's misconduct, not to any deficiency in Ironside's oversight.

Calderwood & Harkness requests the opportunity to review the draft investor notice before distribution to limited partners. This review will be focused on privilege protection, litigation-consistency, and the avoidance of inadvertent admissions. We will endeavor to complete our review within three business days of receipt of a draft.

VI. Recommended Investor Notice Language

A. Key Elements of the Draft Notice

Based on the foregoing analysis, we recommend that the investor notice include the following key elements. These are described in summary form; the actual drafting of the notice will be undertaken by Ironside's in-house team, with Calderwood & Harkness's review as described above.

1. Identification of the Misvaluation. A clear statement that Ironside has identified that its former fund administrator, Vantor Holdings Corp., systematically misvalued certain illiquid credit and structured-product positions across Funds I, II, and III during the period from Q1 2021 through Q3 2023.

2. Scope of the Misvaluation. A statement that an independent valuation review conducted by a qualified third-party valuation firm has identified aggregate overvaluation of approximately $287 million across forty-seven positions. The notice should identify the three affected Funds and provide the aggregate overvaluation figure, but need not identify specific positions by name or CUSIP.

3. Termination of Vantor and Transition to New Administrator. A statement that Ironside terminated its fund administration agreement with Vantor effective October 3, 2023, for cause, and that Ironside has transitioned all fund administration functions to a new, independent fund administrator. Meridian Investor Services may be identified by name in this context.

4. Engagement of Independent Counsel. A general statement that Ironside has engaged independent legal counsel to pursue all available remedies against Vantor, including claims for fraud, breach of contract, and breach of fiduciary duty. The notice should not identify Calderwood & Harkness by name or describe the specific litigation strategy.

5. Corrected NAV Figures and Restated Capital Account Statements. A statement that corrected NAV figures and restated capital account statements will be provided to all limited partners, with an indication of the expected timeline for delivery. If preliminary restated figures are available at the time of the notice, they may be included with appropriate caveats.

6. Disgorgement of Excess Management Fees. A statement that Ironside has offered to disgorge approximately $4.3 million in excess management fees collected as a result of inflated NAV during the misvaluation period. This disclosure serves as a powerful signal of Ironside's good faith and should be included prominently in the notice.

7. Impact on Subscribing and Redeeming Investors. A reference to the impact of the misvaluation on investors who subscribed to or redeemed from the Funds during the affected period, and a description of the process by which Ironside intends to address overpayments to redeeming investors and any mispricing affecting subscribing investors.

8. Contact Information. The notice should provide contact information for questions, directing limited partners to Katherine Lim, General Counsel and Chief Compliance Officer.

9. Forward-Looking Disclaimer. Standard language indicating that the notice may contain forward-looking statements, that actual results may differ materially, and that Ironside undertakes no obligation to update the notice except as required by law.

B. What to Exclude from the Notice

Equally important is what the investor notice should not contain. The following categories of information should be excluded:

• Privileged communications. The notice should not disclose the substance of any communications between Ironside and Calderwood & Harkness, including the legal analysis contained in this letter, the demand letter to Vantor, or any draft complaint or litigation memoranda. Similarly, the Harmon-Bryce valuation report and the Kessler analysis are protected work product and should not be appended to or described in detail in the investor notice.

• Detailed litigation strategy or damage calculations. Beyond the aggregate overvaluation figure of approximately $287 million, the notice should not include detailed damage calculations, break-downs by position, or analyses of the components of Ironside's potential recovery. These calculations are part of the litigation work product and their premature disclosure could prejudice Ironside's negotiating position.

• Identification of specific Vantor personnel. The notice should refer to Vantor as an entity and should not identify specific Vantor employees or officers, including Nathan Orris or Deepa Rajaram, by name. The identification of individuals is a matter for the litigation, not for investor communications.

• Internal investigation details. The notice should not reference the pre-suit subpoena to DataVault Solutions Inc., any internal emails or communications obtained from Vantor, or the specific investigative steps taken by Calderwood & Harkness in the pre-litigation phase.

• Speculation on damages or recoveries. The notice should not speculate on the amount of punitive damages, the likelihood of recovery, the expected timeline of litigation, or any other contingent matter. Doing so would create expectations and could be construed as a forward-looking statement subject to securities law liability.

VII. Risk Considerations

The manner and timing of Ironside's disclosure to its limited partners will materially affect Ironside's exposure to three categories of risk: LP litigation risk, regulatory risk, and reputational risk. We address each in turn.

A. LP Litigation Risk

As noted above, three LP arbitrations are already pending against Ironside, with estimated defense costs of approximately $6.1 million. The risk of additional LP claims — including claims by the 217 investors who redeemed at inflated NAV, claims by current investors whose capital accounts were overstated, and potential class-wide or group claims — is real and significant.

Proactive and transparent disclosure is the single most effective strategy for limiting additional LP claims. Limited partners who feel that they were kept informed, treated fairly, and provided with complete information are materially less likely to initiate litigation than investors who learn of the misvaluation from third-party sources or who perceive that the general partner attempted to conceal or minimize the problem. Conversely, delayed or incomplete disclosure would almost certainly increase the number and severity of LP claims, and would provide claimants with a narrative of concealment that would be damaging both in arbitration and in the court of public opinion.

Ironside's willingness to disgorge excess management fees of approximately $4.3 million should be communicated to limited partners as concrete evidence of the Firm's good faith. This voluntary disgorgement, undertaken before any LP demand or regulatory order, demonstrates that Ironside is prioritizing the interests of its limited partners over its own economic interest. It should be described clearly and prominently in the investor notice.

B. Regulatory Risk

Ironside faces meaningful regulatory risk if its Form ADV and Form PF filings are not amended in a timely manner to reflect the misvaluation and the related legal proceedings. The SEC's Division of Examinations may conduct a risk-based examination of Ironside triggered by the Form ADV amendment itself, or may learn of the misvaluation through other channels (including the pending LP arbitrations or the anticipated litigation against Vantor). In either case, the SEC will scrutinize whether Ironside met its disclosure and regulatory filing obligations promptly and completely.

Proactive filing of amended regulatory documents mitigates this risk significantly. An adviser that self-identifies a problem, takes prompt remedial action, and timely updates its regulatory filings is in a far stronger position vis-à-vis the SEC than one that waits for an examination or enforcement inquiry to force disclosure.

We also note that Ironside should consider whether a voluntary self-report to the SEC's Division of Examinations is warranted. A self-report — while not without risk — can yield meaningful benefits, including the possibility of more favorable treatment in any subsequent enforcement proceeding, credit for cooperation, and the ability to control the narrative rather than responding to an inquiry initiated by the staff. The decision to self-report involves a complex weighing of factors and should be made in consultation with Ironside's in-house legal and compliance team, potentially with the involvement of specialized securities regulation counsel. Calderwood & Harkness is available to consult on the litigation implications of a self-report, but the ultimate decision rests with Ironside.

C. Reputational Risk

The misvaluation and its aftermath present substantial reputational risk to Ironside. Based on preliminary assessments provided by Ironside's business development team, the estimated reputational impact includes approximately $860 million in potential AUM outflows, representing investors who may seek to redeem their interests upon learning of the misvaluation. The capitalized revenue loss associated with those outflows — assuming Ironside's current management fee rate and a reasonable retention period — is estimated at approximately $38.6 million.

While AUM outflows cannot be entirely prevented, transparent and prompt investor communication is the most effective reputational mitigation strategy available. The investor notice and the accompanying outreach to major LPs should be crafted to convey a consistent and compelling narrative. That narrative should emphasize three key points:

(i) Ironside's own internal controls detected the problem. The discrepancy was identified by Ironside's Chief Financial Officer through a comparison of Vantor's marks to independent pricing sources. Ironside did not learn of the misvaluation from an auditor, a regulator, or a whistleblower — it caught the problem itself. This fact is powerful evidence of the integrity of Ironside's risk management and oversight processes.

(ii) Ironside acted swiftly and decisively. Upon identifying the discrepancy, Ironside immediately engaged an independent valuation firm, conducted a comprehensive review, terminated Vantor for cause, transitioned fund administration to a new independent administrator, and retained litigation counsel to pursue recovery. The speed and decisiveness of Ironside's response should be emphasized.

(iii) Ironside is pursuing aggressive legal remedies against Vantor. The engagement of independent counsel and the filing of a demand letter signal Ironside's intention to hold Vantor fully accountable for its misconduct and to seek maximum recovery for the Funds and their limited partners.

This narrative, consistently communicated across all investor-facing touchpoints, will help Ironside retain the confidence of its LP base to the greatest extent possible under the circumstances.

VIII. Next Steps and Action Items

Based on the foregoing analysis, we recommend the following immediate action items. Responsibility is assigned as indicated below. Target dates are included where applicable and should be treated as firm deadlines absent extraordinary circumstances.

1. Katherine Lim to provide Calderwood & Harkness with copies of all three Fund LPAs (Fund I, Fund II, and Fund III) and any side letter agreements with Ashford Endowment Partners LP and other significant limited partners. Target: November 24, 2023.

2. Ironside in-house team to prepare a draft investor notice for Calderwood & Harkness review, incorporating the guidance set forth in Section VI of this letter. Target: first week of December 2023.

3. Elliot Brennan or Marguerite Dao to schedule a telephone call or in-person meeting with Philip Ashford III at Ashford Endowment Partners to provide an individualized briefing on the misvaluation, remedial steps, and planned timeline for corrected reporting. Target: first week of December 2023 (prior to or concurrent with delivery of Ashford's written notice).

4. Katherine Lim to coordinate with Claremont & Strauss LLP (Howard Stein) regarding the audit restatement timeline, including whether restated financial statements are required for fiscal years 2021 and 2022, and the expected timeline for completion. Target: by end of November 2023.

5. Rajiv Subramanian to finalize restated NAV figures for each quarter from Q1 2021 through Q3 2023, in coordination with Meridian Investor Services (Anne-Claire Dupont) and Harmon-Bryce Valuation Advisors LLC. Target: by end of November 2023.

6. Katherine Lim to prepare draft amendments to Form ADV Item 11 and Form PF for Calderwood & Harkness review. Our review will be limited to ensuring consistency with litigation positions and the avoidance of inadvertent privilege waiver; filing responsibility remains with Ironside's in-house team. Target: mid-December 2023.

7. Calderwood & Harkness to remain available to review all investor-facing communications, regulatory filings, and related documents for privilege protection and litigation-consistency issues. We will endeavor to complete each review within three business days of receipt.

We encourage the Ironside team to treat the foregoing timeline as aggressive but achievable. As discussed throughout this letter, the passage of time without disclosure increases Ironside's legal, regulatory, and reputational exposure. Every effort should be made to complete the disclosure process before year-end 2023.

IX. Limitations and Scope of This Letter

This letter constitutes legal advice rendered by Calderwood & Harkness LLP in connection with our engagement to represent Ironside Capital Management LP in litigation against Vantor Holdings Corp. arising from the systematic misvaluation of illiquid credit and structured-product positions across the three Ironside feeder funds. The entirety of this letter is protected by the attorney-client privilege and the attorney work product doctrine and is furnished solely for the use of Ironside and its authorized officers, directors, and in-house counsel. It should not be disclosed to any third party — including limited partners, regulators, auditors, or opposing parties — without the prior written consent of Calderwood & Harkness LLP. Any such disclosure could result in a waiver of the protections afforded by the attorney-client privilege and the work product doctrine.

Calderwood & Harkness's engagement is limited in scope to litigation matters arising from the Vantor misvaluation. Regulatory filings, compliance advice, investor communications, and related operational matters are the responsibility of Ironside's in-house legal and compliance team. While we have provided guidance in this letter regarding the content and timing of investor disclosures, that guidance is offered solely from the perspective of litigation counsel — that is, to ensure that investor-facing communications are consistent with the litigation strategy and do not inadvertently waive privilege, create adverse admissions, or otherwise prejudice Ironside's litigation position.

This letter does not constitute advice on Delaware partnership law or the interpretation of the specific provisions of the Fund limited partnership agreements. It does not constitute advice on compliance with the federal securities laws, the Investment Advisers Act of 1940, or the rules and regulations of the Securities and Exchange Commission, except insofar as those laws and regulations are relevant to the litigation-related analysis set forth herein. It does not constitute tax advice. Ironside should consult specialized counsel as needed on each of these matters.

Nothing in this letter should be construed as a guarantee of any particular outcome in the anticipated litigation against Vantor, in the pending LP arbitrations, or in any regulatory proceeding. The legal analysis and strategic recommendations contained herein are based on the information available to Calderwood & Harkness as of the date of this letter and are subject to revision as additional facts become available.

X. Conclusion

We believe that prompt, transparent, and carefully crafted disclosure to Ironside's limited partners is both legally required and strategically advisable. The misvaluation is material by any standard, and Ironside's fiduciary, contractual, and regulatory obligations compel disclosure. At the same time, the manner in which that disclosure is made will have a significant impact on Ironside's litigation posture, regulatory profile, and ability to retain its investor base. We are confident that, with appropriate coordination between Ironside's in-house team and Calderwood & Harkness, the disclosure process can be managed in a way that fulfills Ironside's obligations, protects its litigation position, and demonstrates the kind of transparency and good faith that Ironside's limited partners deserve.

We are available to discuss any aspect of this letter at your convenience. Please do not hesitate to contact me directly at the number or email address below.

Very truly yours,

CALDERWOOD & HARKNESS LLP

By: ________

Samuel Eklund Partner Direct: (212) 556-4187

Email: seklund@calderwoodharkness.com

Enclosures: None. Referenced documents (including the three Fund LPAs, side letter agreements, Harmon-Bryce preliminary report, and demand letter to Vantor) are to be provided separately under cover of appropriate confidentiality designations.

This communication is intended solely for the use of the addressee(s) and may contain information that is privileged, confidential, and exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, please notify the sender immediately and destroy all copies.

Fund	Aggregate Overvaluation
Ironside Credit Opportunities Fund LP (Fund I)	$156.4 million
Ironside Structured Alpha Fund LP (Fund II)	$88.7 million
Ironside Special Situations Fund LP (Fund III)	$41.9 million
Total	$287.0 million

CALDERWOOD & HARKNESS LLP 51 West 52nd Street, 40th Floor New York, NY 10019 Telephone: (212) 556-4000 Facsimile: (212) 556-4001 www.calderwoodharkness.com
November 20, 2023
Via Email and Hand Delivery
PRIVILEGED AND CONFIDENTIAL — ATTORNEY-CLIENT COMMUNICATION / ATTORNEY WORK PRODUCT
Katherine Lim, Esq. General Counsel & Chief Compliance Officer Ironside Capital Management LP 680 Park Avenue, 34th Floor New York, NY 10065
Re: Investor Communication Considerations — Disclosure Obligations to Limited Partners Arising from Vantor Holdings Corp. Fund Administration Misvaluation
From: Samuel Eklund, Responsible Partner, Calderwood & Harkness LLP
cc: Elliot Brennan, Co-Founder, Managing Partner & Chief Investment Officer, Ironside Capital Management LP Marguerite Dao, Co-Founder, President & Chief Operating Officer, Ironside Capital Management LP Rajiv Subramanian, Chief Financial Officer, Ironside Capital Management LP Linda Osei, Billing Partner, Calderwood & Harkness LLP
Dear Katherine:
We write in connection with our engagement as litigation counsel to Ironside Capital Management LP ("Ironside" or the "Firm") to provide guidance on Ironside's disclosure obligations to the limited partners ("LPs") of its three feeder funds in light of the systematic misvaluation of fund assets by Vantor Holdings Corp. ("Vantor"), Ironside's former fund administrator. This letter is intended to be read in conjunction with our demand letter to Vantor dated November 15, 2023, and the preliminary valuation report delivered by Harmon-Bryce Valuation Advisors LLC on September 22, 2023. The entirety of this letter is protected by the attorney-client privilege and the work product doctrine and should not be disclosed to any third party without the prior written consent of Calderwood & Harkness LLP.
I. Purpose of This Letter
As you are aware, over the course of the past several months, Ironside has uncovered evidence of systematic misvaluation by Vantor Holdings Corp. of illiquid credit and structured-product positions held across Ironside's three feeder fund vehicles: Ironside Credit Opportunities Fund LP ("Fund I"), Ironside Structured Alpha Fund LP ("Fund II"), and Ironside Special Situations Fund LP ("Fund III," and together with Fund I and Fund II, the "Funds"). The misvaluation spans eleven quarters, from the first quarter of 2021 through the third quarter of 2023, and has resulted in an aggregate overvaluation of approximately $287 million. The implications for Ironside's limited partners — and for Ironside itself — are significant and far-reaching.
The purpose of this letter is to provide Ironside's in-house legal and compliance team with guidance regarding the Firm's obligations to disclose the Vantor misvaluation to the limited partners of the three affected Funds. Specifically, we address: (a) the legal framework governing LP disclosure obligations, including the applicable provisions of the limited partnership agreements, federal securities laws, and the Investment Advisers Act of 1940; (b) the identification of key investors requiring special attention; (c) our recommended disclosure approach and timeline; (d) suggested parameters for the content of the investor notice, including both what to include and what to exclude in order to protect litigation strategy and attorney-client privilege; and (e) certain risk considerations that should inform Ironside's approach.
By way of procedural context, we note the following significant recent developments:
•  Ironside terminated the Master Fund Administration Agreement with Vantor (the "FAA," dated June 15, 2017; Reference No. VHC-ICM-2017-0615) for cause on October 3, 2023, pursuant to Section 12.2 of the FAA, following the completion of an initial internal investigation and the receipt of independent valuation analysis confirming material overvaluation across all three Funds.
•  Ironside transitioned fund administration functions to Meridian Investor Services LLC ("Meridian"), under the direction of Meridian's Chief Executive Officer, Anne-Claire Dupont, effective October 10, 2023. The transition was completed on an expedited basis and Meridian has assumed responsibility for all ongoing NAV calculations, capital account recordkeeping, and investor reporting.
•  Calderwood & Harkness transmitted a formal demand letter to Vantor on November 15, 2023, setting forth the factual basis for Ironside's claims and demanding, among other things, full restitution of all damages arising from the misvaluation. The investor communication analysis set forth in this letter runs in parallel with our pre-litigation demand process and will be coordinated to ensure consistency between the two.
We wish to emphasize that this letter is advisory in nature. Ironside's in-house legal and compliance team, under your leadership, will ultimately bear responsibility for managing regulatory filings and investor communications. Calderwood & Harkness's role is limited to providing litigation counsel guidance — specifically, to ensure that investor-facing communications are consistent with the factual narrative underlying our litigation strategy, do not inadvertently waive privilege or work product protections, and do not contain statements that could be used adversely by Vantor or other parties in subsequent proceedings. We are not opining on matters of Delaware partnership law, securities regulation compliance, or tax, and we encourage you to engage specialized counsel as needed on those matters.
II. Background Summary for Context
We provide the following factual summary for context. This summary draws on the preliminary report of Harmon-Bryce Valuation Advisors LLC and on the internal findings of Ironside's finance and operations teams. It is not intended to be exhaustive; rather, it is designed to frame the disclosure analysis that follows.
A. Discovery and Independent Valuation
In July 2023, Rajiv Subramanian, Ironside's Chief Financial Officer, identified a discrepancy of approximately $12.6 million across seven CLO equity positions when he compared Vantor's marks to independent pricing indications provided by Northpoint Securities. Mr. Subramanian escalated the discrepancy to you and to the Firm's senior leadership, and Ironside promptly engaged Harmon-Bryce Valuation Advisors LLC ("Harmon-Bryce"), an independent valuation firm led by Dr. Lena Galbraith, CFA, ASA, to conduct a comprehensive review of all illiquid credit and structured-product positions across the three Funds.
Harmon-Bryce delivered its preliminary report on September 22, 2023 (Reference No. HBVA-2023-0922-IRON). The report identified forty-seven (47) mispriced illiquid positions across the three Funds, spanning CLO equity tranches, bespoke CDO mezzanine notes, and distressed loan participations. The misvaluation was systematic in nature and persisted over eleven consecutive quarters.
B. Magnitude of the Overvaluation
The aggregate overvaluation identified by Harmon-Bryce is as follows:
The average mark inflation across the affected positions was approximately 14.3% above observable inputs. The overvaluation of NAV per unit ranged from approximately 3.8% in the first quarter of 2021 — the earliest affected period — to a peak of approximately 8.6% in the fourth quarter of 2022. The single-quarter overvaluation reached its maximum of approximately $52.3 million in the fourth quarter of 2022, coinciding with a period of significant dislocation in credit markets and wider bid-ask spreads in the affected asset classes.
C. Consequences of the Misvaluation
The misvaluation has produced a number of concrete adverse consequences for Ironside and its limited partners, which we summarize as follows:
Overpayments to Redeeming LPs. During the eleven-quarter misvaluation period, Ironside processed 217 investor redemptions at inflated NAV, resulting in aggregate overpayments to redeeming limited partners of approximately $43.2 million. These overpayments were funded from the remaining assets of the Funds, thereby diluting the interests of non-redeeming limited partners.
Excess Management Fees. Ironside collects a management fee at an annual rate of 1.5% of net asset value. Because NAV was overstated during the misvaluation period, Ironside collected excess management fees of approximately $4.3 million. Ironside has offered to disgorge these amounts in full, a decision that we commend as both ethically appropriate and strategically valuable in mitigating LP claims and regulatory exposure.
Inflated Performance Allocations. The Funds' performance allocation is calculated at a rate of 20% of net profits above a 6% annualized hurdle rate. To the extent that the inflated NAV figures caused the performance allocation to be calculated on overstated returns, the general partner may have received performance allocations to which it was not entitled. The precise quantum of excess performance allocations is being calculated by Meridian Investor Services in coordination with Harmon-Bryce and will be included in the restated capital account statements.
Misstated Capital Account Balances. Both subscribing and redeeming investors received capital account statements reflecting inflated balances. Subscribing investors who entered the Funds during the misvaluation period may have acquired interests at prices above true NAV, while redeeming investors received proceeds in excess of their true entitlements. The resulting misallocation of value among limited partners will need to be addressed through the restatement process.
Misstated Regulatory Filings. Ironside's regulatory filings during the misvaluation period, including Form PF (filed with the SEC on a quarterly basis) and Form ADV (updated annually and as required upon the occurrence of material events), contained NAV figures and position-level data derived from Vantor's inflated valuations. These filings will need to be corrected.
Audit Implications. Ironside's independent auditor, Claremont & Strauss LLP, under the direction of audit partner Howard Stein, issued unqualified audit opinions on the financial statements of the three Funds for the fiscal years ended December 31, 2021 and December 31, 2022. To the extent that the misvaluation was material to those financial statements, restatement may be required. We understand that Katherine Lim will coordinate directly with Mr. Stein regarding the audit restatement timeline.
Pending LP Arbitrations. Three limited partners have initiated arbitration proceedings against Ironside, alleging damages arising from the misvaluation. We understand that the estimated defense costs for these three proceedings are approximately $6.1 million. These arbitrations underscore the urgency of proactive investor communication to limit the risk of additional claims.
III. Legal Framework for LP Disclosure Obligations
This section analyzes the principal sources of law and contractual obligation that govern Ironside's duty to disclose the Vantor misvaluation to its limited partners. As noted above, our analysis is informed by our litigation-counsel perspective and is not intended to substitute for a comprehensive securities regulation or partnership law opinion.
A. Limited Partnership Agreement Provisions
Each of the three Fund limited partnership agreements (the "LPAs") contains provisions relating to investor notification upon the occurrence of material events, changes to NAV methodology or NAV calculations, and the initiation of litigation or arbitration proceedings involving the Fund. Although we have not yet completed our review of the LPAs — we have requested that you provide Calderwood & Harkness with copies of all three Fund LPAs, along with any side letter agreements — the disclosure provisions in fund limited partnership agreements of this type typically require the general partner to provide prompt written notice to limited partners of any event that would materially affect the computation of NAV or the determination of capital account balances.
The discovery of a $287 million aggregate overvaluation, spanning eleven quarters and affecting forty-seven positions across three Funds, is unquestionably material under any reasonable interpretation of the LPA notification provisions. The overvaluation resulted in NAV per unit being overstated by as much as 8.6% in a single quarter. It affected both subscribing and redeeming investors. It resulted in $43.2 million in overpayments. Under these circumstances, we believe it is beyond serious dispute that the LPAs require prompt written notice to the limited partners.
We recommend that Ironside's in-house team conduct a detailed review of the specific notification provisions in each of the three LPAs, including any differences among the Funds in the scope or timing of required disclosures. In addition, any side letter agreements that grant particular limited partners enhanced information rights, inspection rights, or reporting rights should be identified and reviewed. We understand that Ashford Endowment Partners LP, in particular, may hold side letter rights that expand upon the baseline LPA disclosure obligations.
More broadly, we note that the general partner of each Fund owes a duty of good faith and fair dealing to the limited partners under the Delaware Revised Uniform Limited Partnership Act ("DRULPA"), 6 Del. C. § 17-1101(d). While the LPAs may modify or limit certain default fiduciary duties — as is common in Delaware limited partnerships — the implied covenant of good faith and fair dealing cannot be eliminated by contract. A failure to disclose a known and material misvaluation of fund assets could be challenged by limited partners as a breach of this covenant, particularly where the general partner has actual knowledge of the overvaluation and the means to correct it.
B. Regulation D Obligations
The offerings of interests in the three Funds were conducted pursuant to Regulation D under the Securities Act of 1933 (the "Securities Act"), relying on the exemption from registration provided by Rule 506(b) or Rule 506(c), as applicable. Regulation D does not, by its own terms, impose a standalone ongoing disclosure obligation on issuers following the completion of an offering. However, the anti-fraud provisions of the federal securities laws apply with full force to all offerings, whether registered or exempt, and those provisions impose affirmative duties in the circumstances present here.
Specifically, Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder prohibit any person from making any untrue statement of a material fact, or omitting to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, in connection with the purchase or sale of any security. Similarly, Section 17(a) of the Securities Act prohibits the use of any device, scheme, or artifice to defraud, or any untrue statement or omission of a material fact, in the offer or sale of securities.
To the extent that any limited partner is currently in the process of subscribing to one of the Funds — or has recently subscribed — based on NAV figures or capital account balances that were materially inflated by Vantor's misvaluation, the failure to disclose the overvaluation could give rise to liability under these anti-fraud provisions. The materiality of the overvaluation is not in doubt: an aggregate misstatement of $287 million, with single-quarter overvaluation as high as $52.3 million and NAV per unit inflation as high as 8.6%, would plainly be considered material by a reasonable investor.
Furthermore, any capital account statements, quarterly NAV reports, investor letters, or other communications distributed to limited partners during the Q1 2021 through Q3 2023 period that contained NAV figures derived from Vantor's inflated valuations were, in retrospect, materially misleading. While those communications were not intentionally misleading by Ironside — the misvaluation originated with Vantor — Ironside now has actual knowledge that the information was incorrect. Under these circumstances, the anti-fraud provisions require Ironside to take reasonable steps to correct the record. Continued silence, once Ironside is aware of the misstatement, could transform what was initially an innocent misrepresentation into a potentially actionable omission.
C. Investment Advisers Act of 1940 — Fiduciary Duties
Ironside is registered with the Securities and Exchange Commission as an investment adviser (SEC CRD No. 158742; SEC File No. 801-79534). As a registered investment adviser, Ironside owes fiduciary duties to its fund clients and, by extension, to the limited partners who are the beneficial owners of the fund assets. These fiduciary duties have been recognized by the Supreme Court in SEC v. Capital Gains Research Bureau, Inc., 375 U.S. 180 (1963), and are the cornerstone of the regulatory framework governing investment advisers.
The fiduciary duties of an investment adviser include, among other things, the obligation to disclose all material facts and conflicts of interest to clients. The SEC has consistently taken the position that an adviser's fiduciary duty encompasses a duty of full and fair disclosure — that is, an affirmative obligation to provide clients with all information material to the advisory relationship, including information relating to the valuation of client assets.
The Vantor misvaluation is, by any measure, a material fact that must be disclosed to the limited partners. The overvaluation directly affects the value of each limited partner's investment, the accuracy of historical performance figures, the reliability of NAV-based reporting, and the fairness of past redemptions and subscriptions. A failure to disclose the misvaluation — particularly now that Ironside has actual knowledge of it — could be characterized by regulators or litigants as a breach of Ironside's fiduciary duty. This is so notwithstanding the fact that the misvaluation originated with Vantor rather than with Ironside itself. An investment adviser's fiduciary duty does not permit it to remain silent once it becomes aware that the information it has provided to clients is materially inaccurate.
We also note the overlap between these fiduciary duties and Ironside's obligations under Form ADV Part 2A (the "brochure"), which requires the adviser to describe material risks and conflicts of interest. While the brochure is typically updated on an annual basis, material changes must be communicated to clients promptly through an amended brochure or a summary of material changes.
D. Form ADV Item 11 and Form PF
Turning to specific regulatory filing obligations, we note two areas of immediate concern.
Form ADV Item 11. Item 11 of Form ADV Part 1A requires the adviser to disclose certain disciplinary and legal events, including pending or concluded legal proceedings that are material to an evaluation of the adviser's integrity or ability to meet contractual commitments to clients. The anticipated litigation against Vantor — which we intend to initiate following the expiration of the demand period — and the three pending LP arbitrations likely trigger the Item 11 disclosure obligation. Ironside should assess whether the filing of a Form ADV amendment is required and, if so, should prepare the amendment promptly.
Form PF. Form PF requires large private fund advisers to report, on a quarterly basis, certain information about the private funds they manage, including NAV, gross and net asset values, borrowings, and investor concentration data. To the extent that Ironside's prior Form PF filings contained NAV figures and position-level data derived from Vantor's inflated valuations, amendments to those filings may be required.
We wish to note explicitly that regulatory filings are outside the scope of Calderwood & Harkness's litigation-focused engagement. The preparation and filing of amendments to Form ADV and Form PF will be handled by Katherine Lim and Ironside's in-house legal and compliance team. However, because statements in regulatory filings could be used by Vantor or other adverse parties in litigation, we request the opportunity to review draft disclosures for consistency with the factual narrative underlying our litigation positions before those filings are submitted. This is a narrow review focused solely on litigation-consistency and privilege issues; it does not expand the scope of our engagement.
Finally, we recommend that Ironside coordinate with Claremont & Strauss LLP, and specifically with audit partner Howard Stein, regarding the audit implications of the misvaluation. If the aggregate overvaluation is material to the audited financial statements for fiscal years 2021 and 2022, restated financial statements may be required, and the timing of any restatement should be coordinated with the investor notification process described in Section V below.
IV. Key Investors Requiring Special Attention
While all limited partners of the three Funds are entitled to receive notice of the Vantor misvaluation, certain investors warrant individualized attention due to the size of their commitments, their contractual rights, or the particular impact of the misvaluation on their capital accounts.
A. Ashford Endowment Partners LP
Ashford Endowment Partners LP ("Ashford") is the lead limited partner across the three Funds, with aggregate committed capital of approximately $340 million. Ashford's principal contact is Philip Ashford III, Managing Director, and its offices are located at 55 Church Street, Suite 800, New Haven, Connecticut 06510.
As the largest investor in the Funds, Ashford's capital account balances have been materially misstated for each of the eleven quarters during which the misvaluation persisted. The dollar magnitude of the overstatement attributable to Ashford's accounts — which, given Ashford's proportionate share of total fund assets, may be in the range of tens of millions of dollars — is significant by any measure.
Moreover, Ashford's position as lead LP is likely accompanied by a suite of enhanced contractual rights. Based on our experience with fund structures of this type, and subject to our review of the actual side letter agreements, we anticipate that Ashford may hold most-favored-nation ("MFN") side letter provisions, enhanced information and transparency rights (potentially including the right to receive position-level reporting, portfolio analytics, or risk metrics on a more frequent basis than other LPs), advisory committee membership, and enhanced audit or inspection rights that could entitle Ashford to more detailed disclosure than the general LP population. Each of these rights should be identified and assessed to ensure that the disclosure provided to Ashford satisfies any heightened obligations.
Given the size of Ashford's commitment and the likely breadth of its contractual rights, we strongly recommend individualized communication with Ashford in advance of the general LP notice. This communication should take the form of a direct telephone call or in-person meeting between Ashford's leadership and Ironside's senior management — ideally Elliot Brennan and/or Marguerite Dao — followed by a detailed written communication tailored to Ashford's specific accounts and contractual entitlements. The purpose of this individualized outreach is twofold: first, to fulfill any enhanced disclosure obligations that Ashford's side letters may impose; and second, to demonstrate Ironside's commitment to transparency and proactive engagement, thereby mitigating the risk that Ashford will join or initiate LP arbitration proceedings. As noted above, three LP arbitrations are already pending, and the addition of a claimant of Ashford's size and sophistication would materially increase both the stakes and the cost of those proceedings.
B. Other Institutional and Significant LPs
Beyond Ashford, we recommend that Ironside identify all limited partners with committed capital above a defined threshold — we suggest $50 million as the initial threshold, to be adjusted based on the actual LP roster — for priority outreach. These investors are likely to include institutional allocators such as pension funds, endowments, foundations, insurance companies, and fund-of-funds vehicles, many of which will have their own reporting, disclosure, and governance obligations that are triggered by the misvaluation. Providing these investors with advance notice (or, at a minimum, contemporaneous notice accompanied by a higher level of detail) will serve both Ironside's legal obligations and its business interests.
In addition, the 217 limited partners who redeemed their interests during the misvaluation period — and who collectively received overpayments totaling approximately $43.2 million — will require specific communications addressing the NAV restatement and the potential mechanisms for addressing those overpayments. The communication to redeeming LPs should explain the basis for the restatement, quantify the estimated overpayment attributable to each redeemer's specific redemption, and describe the process by which Ironside intends to address the overpayments, whether through clawback, offset against future distributions, or negotiated resolution. The legal authority for clawback or offset will depend on the specific provisions of the applicable LPA and any side letter, and we recommend that Ironside's in-house team conduct a thorough analysis of those provisions.
V. Recommended Disclosure Approach and Timeline
A. General Principles
Based on our experience in similar matters and our assessment of the legal framework described above, we recommend that Ironside's investor disclosure be guided by the following general principles:
Promptness. Ironside should disclose the misvaluation to its limited partners as promptly as practicable. Delay in disclosure increases Ironside's exposure to claims by limited partners that the Firm failed to meet its fiduciary and contractual obligations, and it erodes the investor confidence that Ironside will need to retain its LP base. Given that Ironside first identified the discrepancy in July 2023 and received the Harmon-Bryce preliminary report in September 2023, the passage of time is already a concern. The goal should be to complete the disclosure process before the end of 2023.
Factual and Measured Tone. The investor notice should be factual, measured, and professional. It should describe the misvaluation in objective terms, acknowledge its impact on the limited partners, and set forth the remedial steps that Ironside has taken and will take. The notice should not contain inflammatory or emotionally charged characterizations of Vantor's conduct. While we believe the evidence supports claims of fraud and intentional misconduct by Vantor, those characterizations belong in the demand letter and the eventual complaint — not in an investor communication. An overwrought or accusatory tone in the investor notice could undermine Ironside's credibility with its LPs and could be characterized by Vantor as prejudicial in the litigation.
Remedial Focus. The notice should emphasize the remedial steps that Ironside has taken, including the termination of Vantor, the retention of Meridian Investor Services as the new fund administrator, the engagement of Harmon-Bryce as an independent valuation firm, and the engagement of independent litigation counsel. This narrative reinforces Ironside's diligence and good faith.
Avoid Speculation. The notice should not speculate on the ultimate amount of damages that Ironside or its LPs may recover from Vantor, the likely timeline or outcome of litigation, or any other contingent matter. Speculative statements create expectations that may not be fulfilled and could be used adversely in subsequent proceedings.
Privilege Protection. The investor notice itself should not disclose the substance of any attorney-client communications between Ironside and Calderwood & Harkness, or any attorney work product (including the detailed analysis in the Harmon-Bryce report, the Kessler analysis, or the strategic assessments contained in this letter and other Calderwood & Harkness correspondence). The notice should reference the retention of counsel only in general terms — e.g., "Ironside has engaged independent legal counsel to pursue all available remedies against Vantor" — without identifying Calderwood & Harkness by name, disclosing the specific theories of liability, or revealing any aspect of the litigation strategy.
B. Recommended Sequence
We recommend that Ironside proceed in the following sequence:
Step 1: Internal Preparation (immediate; target completion by end of November 2023). Ironside should finalize the restated NAV figures for each quarter from Q1 2021 through Q3 2023, in coordination with Meridian Investor Services and Harmon-Bryce. Rajiv Subramanian should lead this effort, with support from the relevant teams at Meridian (under the direction of Anne-Claire Dupont) and Harmon-Bryce. Concurrently, Katherine Lim should coordinate with Claremont & Strauss LLP (Howard Stein) to determine whether audited financial statement restatements are required and, if so, the expected timeline for completion. The restated NAV figures and any auditor communications should be finalized before the first investor outreach occurs, so that Ironside is prepared to provide complete and accurate corrected data.
Step 2: Individualized Outreach to Ashford Endowment Partners and Other Major LPs (target: first week of December 2023). Ironside's senior leadership — Elliot Brennan and/or Marguerite Dao — should arrange a telephone call or, if feasible, an in-person meeting with Philip Ashford III at Ashford Endowment Partners to brief Ashford on the misvaluation, the remedial steps taken, and the planned timeline for providing corrected NAV figures and capital account statements. This call or meeting should be followed by a written communication to Ashford that is tailored to Ashford's specific accounts and contractual rights. Similar outreach should be conducted with other significant LPs identified through the prioritization process described in Section IV.B above.
Step 3: General LP Notice (target: mid-December 2023). Following the completion of individualized outreach to major LPs, Ironside should distribute a written notice to all limited partners of the three affected Funds. The notice should include the key elements described in Section VI below, including corrected NAV figures (if finalized by that date), a description of the misvaluation, the remedial steps taken, and contact information for questions. If finalized restated NAV figures are not yet available, the notice should indicate the expected date of delivery and provide preliminary estimates, with appropriate caveats.
Step 4: Follow-Up Capital Account Statements (target: January 2024). Ironside should distribute corrected capital account statements to all current and former limited partners, reflecting restated NAV for each quarter from Q1 2021 through Q3 2023. These statements should clearly identify the original (overstated) figures and the corrected figures for each period, together with explanatory notes describing the basis for the restatement.
Step 5: Regulatory Filings (concurrent with the above steps). Amendments to Form ADV Item 11 and Form PF should be prepared and filed on a timeline consistent with the investor notification process. As discussed in Section III.D, Calderwood & Harkness requests the opportunity to review draft regulatory filings for litigation-consistency purposes prior to submission, but the filing responsibility rests with Ironside's in-house team.
C. Coordination with Litigation Strategy
It is essential that the investor notice be consistent with the factual narrative set forth in our demand letter to Vantor and in the complaint that we anticipate filing if the demand is not satisfied. To that end, we offer the following specific guidance:
The investor notice should not contain any admissions or characterizations that could be used adversely by Vantor in litigation. In particular, the notice should not suggest or imply that Ironside was itself negligent in overseeing Vantor's valuation work. While Vantor can be expected to raise comparative fault or contributory negligence defenses — arguing that Ironside failed to detect the misvaluation sooner — there is no reason for Ironside to provide Vantor with ammunition for those arguments in its own investor communications.
To the contrary, the notice should affirmatively emphasize that Ironside discovered the misvaluation through its own internal controls and monitoring processes. Specifically, the notice should reference (in general terms) that Ironside's Chief Financial Officer identified discrepancies in Vantor's valuations, that Ironside promptly engaged an independent valuation firm to conduct a comprehensive review, and that Ironside acted swiftly upon confirmation of the misvaluation to terminate Vantor, engage a new administrator, and retain litigation counsel. This narrative is not only factually accurate — it directly supports Ironside's litigation position that the misvaluation was attributable to Vantor's misconduct, not to any deficiency in Ironside's oversight.
Calderwood & Harkness requests the opportunity to review the draft investor notice before distribution to limited partners. This review will be focused on privilege protection, litigation-consistency, and the avoidance of inadvertent admissions. We will endeavor to complete our review within three business days of receipt of a draft.
VI. Recommended Investor Notice Language
A. Key Elements of the Draft Notice
Based on the foregoing analysis, we recommend that the investor notice include the following key elements. These are described in summary form; the actual drafting of the notice will be undertaken by Ironside's in-house team, with Calderwood & Harkness's review as described above.
1.  Identification of the Misvaluation. A clear statement that Ironside has identified that its former fund administrator, Vantor Holdings Corp., systematically misvalued certain illiquid credit and structured-product positions across Funds I, II, and III during the period from Q1 2021 through Q3 2023.
2.  Scope of the Misvaluation. A statement that an independent valuation review conducted by a qualified third-party valuation firm has identified aggregate overvaluation of approximately $287 million across forty-seven positions. The notice should identify the three affected Funds and provide the aggregate overvaluation figure, but need not identify specific positions by name or CUSIP.
3.  Termination of Vantor and Transition to New Administrator. A statement that Ironside terminated its fund administration agreement with Vantor effective October 3, 2023, for cause, and that Ironside has transitioned all fund administration functions to a new, independent fund administrator. Meridian Investor Services may be identified by name in this context.
4.  Engagement of Independent Counsel. A general statement that Ironside has engaged independent legal counsel to pursue all available remedies against Vantor, including claims for fraud, breach of contract, and breach of fiduciary duty. The notice should not identify Calderwood & Harkness by name or describe the specific litigation strategy.
5.  Corrected NAV Figures and Restated Capital Account Statements. A statement that corrected NAV figures and restated capital account statements will be provided to all limited partners, with an indication of the expected timeline for delivery. If preliminary restated figures are available at the time of the notice, they may be included with appropriate caveats.
6.  Disgorgement of Excess Management Fees. A statement that Ironside has offered to disgorge approximately $4.3 million in excess management fees collected as a result of inflated NAV during the misvaluation period. This disclosure serves as a powerful signal of Ironside's good faith and should be included prominently in the notice.
7.  Impact on Subscribing and Redeeming Investors. A reference to the impact of the misvaluation on investors who subscribed to or redeemed from the Funds during the affected period, and a description of the process by which Ironside intends to address overpayments to redeeming investors and any mispricing affecting subscribing investors.
8.  Contact Information. The notice should provide contact information for questions, directing limited partners to Katherine Lim, General Counsel and Chief Compliance Officer.
9.  Forward-Looking Disclaimer. Standard language indicating that the notice may contain forward-looking statements, that actual results may differ materially, and that Ironside undertakes no obligation to update the notice except as required by law.
B. What to Exclude from the Notice
Equally important is what the investor notice should not contain. The following categories of information should be excluded:
•  Privileged communications. The notice should not disclose the substance of any communications between Ironside and Calderwood & Harkness, including the legal analysis contained in this letter, the demand letter to Vantor, or any draft complaint or litigation memoranda. Similarly, the Harmon-Bryce valuation report and the Kessler analysis are protected work product and should not be appended to or described in detail in the investor notice.
•  Detailed litigation strategy or damage calculations. Beyond the aggregate overvaluation figure of approximately $287 million, the notice should not include detailed damage calculations, break-downs by position, or analyses of the components of Ironside's potential recovery. These calculations are part of the litigation work product and their premature disclosure could prejudice Ironside's negotiating position.
•  Identification of specific Vantor personnel. The notice should refer to Vantor as an entity and should not identify specific Vantor employees or officers, including Nathan Orris or Deepa Rajaram, by name. The identification of individuals is a matter for the litigation, not for investor communications.
•  Internal investigation details. The notice should not reference the pre-suit subpoena to DataVault Solutions Inc., any internal emails or communications obtained from Vantor, or the specific investigative steps taken by Calderwood & Harkness in the pre-litigation phase.
•  Speculation on damages or recoveries. The notice should not speculate on the amount of punitive damages, the likelihood of recovery, the expected timeline of litigation, or any other contingent matter. Doing so would create expectations and could be construed as a forward-looking statement subject to securities law liability.
VII. Risk Considerations
The manner and timing of Ironside's disclosure to its limited partners will materially affect Ironside's exposure to three categories of risk: LP litigation risk, regulatory risk, and reputational risk. We address each in turn.
A. LP Litigation Risk
As noted above, three LP arbitrations are already pending against Ironside, with estimated defense costs of approximately $6.1 million. The risk of additional LP claims — including claims by the 217 investors who redeemed at inflated NAV, claims by current investors whose capital accounts were overstated, and potential class-wide or group claims — is real and significant.
Proactive and transparent disclosure is the single most effective strategy for limiting additional LP claims. Limited partners who feel that they were kept informed, treated fairly, and provided with complete information are materially less likely to initiate litigation than investors who learn of the misvaluation from third-party sources or who perceive that the general partner attempted to conceal or minimize the problem. Conversely, delayed or incomplete disclosure would almost certainly increase the number and severity of LP claims, and would provide claimants with a narrative of concealment that would be damaging both in arbitration and in the court of public opinion.
Ironside's willingness to disgorge excess management fees of approximately $4.3 million should be communicated to limited partners as concrete evidence of the Firm's good faith. This voluntary disgorgement, undertaken before any LP demand or regulatory order, demonstrates that Ironside is prioritizing the interests of its limited partners over its own economic interest. It should be described clearly and prominently in the investor notice.
B. Regulatory Risk
Ironside faces meaningful regulatory risk if its Form ADV and Form PF filings are not amended in a timely manner to reflect the misvaluation and the related legal proceedings. The SEC's Division of Examinations may conduct a risk-based examination of Ironside triggered by the Form ADV amendment itself, or may learn of the misvaluation through other channels (including the pending LP arbitrations or the anticipated litigation against Vantor). In either case, the SEC will scrutinize whether Ironside met its disclosure and regulatory filing obligations promptly and completely.
Proactive filing of amended regulatory documents mitigates this risk significantly. An adviser that self-identifies a problem, takes prompt remedial action, and timely updates its regulatory filings is in a far stronger position vis-à-vis the SEC than one that waits for an examination or enforcement inquiry to force disclosure.
We also note that Ironside should consider whether a voluntary self-report to the SEC's Division of Examinations is warranted. A self-report — while not without risk — can yield meaningful benefits, including the possibility of more favorable treatment in any subsequent enforcement proceeding, credit for cooperation, and the ability to control the narrative rather than responding to an inquiry initiated by the staff. The decision to self-report involves a complex weighing of factors and should be made in consultation with Ironside's in-house legal and compliance team, potentially with the involvement of specialized securities regulation counsel. Calderwood & Harkness is available to consult on the litigation implications of a self-report, but the ultimate decision rests with Ironside.
C. Reputational Risk
The misvaluation and its aftermath present substantial reputational risk to Ironside. Based on preliminary assessments provided by Ironside's business development team, the estimated reputational impact includes approximately $860 million in potential AUM outflows, representing investors who may seek to redeem their interests upon learning of the misvaluation. The capitalized revenue loss associated with those outflows — assuming Ironside's current management fee rate and a reasonable retention period — is estimated at approximately $38.6 million.
While AUM outflows cannot be entirely prevented, transparent and prompt investor communication is the most effective reputational mitigation strategy available. The investor notice and the accompanying outreach to major LPs should be crafted to convey a consistent and compelling narrative. That narrative should emphasize three key points:
(i) Ironside's own internal controls detected the problem. The discrepancy was identified by Ironside's Chief Financial Officer through a comparison of Vantor's marks to independent pricing sources. Ironside did not learn of the misvaluation from an auditor, a regulator, or a whistleblower — it caught the problem itself. This fact is powerful evidence of the integrity of Ironside's risk management and oversight processes.
(ii) Ironside acted swiftly and decisively. Upon identifying the discrepancy, Ironside immediately engaged an independent valuation firm, conducted a comprehensive review, terminated Vantor for cause, transitioned fund administration to a new independent administrator, and retained litigation counsel to pursue recovery. The speed and decisiveness of Ironside's response should be emphasized.
(iii) Ironside is pursuing aggressive legal remedies against Vantor. The engagement of independent counsel and the filing of a demand letter signal Ironside's intention to hold Vantor fully accountable for its misconduct and to seek maximum recovery for the Funds and their limited partners.
This narrative, consistently communicated across all investor-facing touchpoints, will help Ironside retain the confidence of its LP base to the greatest extent possible under the circumstances.
VIII. Next Steps and Action Items
Based on the foregoing analysis, we recommend the following immediate action items. Responsibility is assigned as indicated below. Target dates are included where applicable and should be treated as firm deadlines absent extraordinary circumstances.
1.  Katherine Lim to provide Calderwood & Harkness with copies of all three Fund LPAs (Fund I, Fund II, and Fund III) and any side letter agreements with Ashford Endowment Partners LP and other significant limited partners. Target: November 24, 2023.
2.  Ironside in-house team to prepare a draft investor notice for Calderwood & Harkness review, incorporating the guidance set forth in Section VI of this letter. Target: first week of December 2023.
3.  Elliot Brennan or Marguerite Dao to schedule a telephone call or in-person meeting with Philip Ashford III at Ashford Endowment Partners to provide an individualized briefing on the misvaluation, remedial steps, and planned timeline for corrected reporting. Target: first week of December 2023 (prior to or concurrent with delivery of Ashford's written notice).
4.  Katherine Lim to coordinate with Claremont & Strauss LLP (Howard Stein) regarding the audit restatement timeline, including whether restated financial statements are required for fiscal years 2021 and 2022, and the expected timeline for completion. Target: by end of November 2023.
5.  Rajiv Subramanian to finalize restated NAV figures for each quarter from Q1 2021 through Q3 2023, in coordination with Meridian Investor Services (Anne-Claire Dupont) and Harmon-Bryce Valuation Advisors LLC. Target: by end of November 2023.
6.  Katherine Lim to prepare draft amendments to Form ADV Item 11 and Form PF for Calderwood & Harkness review. Our review will be limited to ensuring consistency with litigation positions and the avoidance of inadvertent privilege waiver; filing responsibility remains with Ironside's in-house team. Target: mid-December 2023.
7.  Calderwood & Harkness to remain available to review all investor-facing communications, regulatory filings, and related documents for privilege protection and litigation-consistency issues. We will endeavor to complete each review within three business days of receipt.
We encourage the Ironside team to treat the foregoing timeline as aggressive but achievable. As discussed throughout this letter, the passage of time without disclosure increases Ironside's legal, regulatory, and reputational exposure. Every effort should be made to complete the disclosure process before year-end 2023.
IX. Limitations and Scope of This Letter
This letter constitutes legal advice rendered by Calderwood & Harkness LLP in connection with our engagement to represent Ironside Capital Management LP in litigation against Vantor Holdings Corp. arising from the systematic misvaluation of illiquid credit and structured-product positions across the three Ironside feeder funds. The entirety of this letter is protected by the attorney-client privilege and the attorney work product doctrine and is furnished solely for the use of Ironside and its authorized officers, directors, and in-house counsel. It should not be disclosed to any third party — including limited partners, regulators, auditors, or opposing parties — without the prior written consent of Calderwood & Harkness LLP. Any such disclosure could result in a waiver of the protections afforded by the attorney-client privilege and the work product doctrine.
Calderwood & Harkness's engagement is limited in scope to litigation matters arising from the Vantor misvaluation. Regulatory filings, compliance advice, investor communications, and related operational matters are the responsibility of Ironside's in-house legal and compliance team. While we have provided guidance in this letter regarding the content and timing of investor disclosures, that guidance is offered solely from the perspective of litigation counsel — that is, to ensure that investor-facing communications are consistent with the litigation strategy and do not inadvertently waive privilege, create adverse admissions, or otherwise prejudice Ironside's litigation position.
This letter does not constitute advice on Delaware partnership law or the interpretation of the specific provisions of the Fund limited partnership agreements. It does not constitute advice on compliance with the federal securities laws, the Investment Advisers Act of 1940, or the rules and regulations of the Securities and Exchange Commission, except insofar as those laws and regulations are relevant to the litigation-related analysis set forth herein. It does not constitute tax advice. Ironside should consult specialized counsel as needed on each of these matters.
Nothing in this letter should be construed as a guarantee of any particular outcome in the anticipated litigation against Vantor, in the pending LP arbitrations, or in any regulatory proceeding. The legal analysis and strategic recommendations contained herein are based on the information available to Calderwood & Harkness as of the date of this letter and are subject to revision as additional facts become available.
X. Conclusion
We believe that prompt, transparent, and carefully crafted disclosure to Ironside's limited partners is both legally required and strategically advisable. The misvaluation is material by any standard, and Ironside's fiduciary, contractual, and regulatory obligations compel disclosure. At the same time, the manner in which that disclosure is made will have a significant impact on Ironside's litigation posture, regulatory profile, and ability to retain its investor base. We are confident that, with appropriate coordination between Ironside's in-house team and Calderwood & Harkness, the disclosure process can be managed in a way that fulfills Ironside's obligations, protects its litigation position, and demonstrates the kind of transparency and good faith that Ironside's limited partners deserve.
We are available to discuss any aspect of this letter at your convenience. Please do not hesitate to contact me directly at the number or email address below.
Very truly yours,
CALDERWOOD & HARKNESS LLP
By: ________
Samuel Eklund Partner Direct: (212) 556-4187
Email: seklund@calderwoodharkness.com
Enclosures: None. Referenced documents (including the three Fund LPAs, side letter agreements, Harmon-Bryce preliminary report, and demand letter to Vantor) are to be provided separately under cover of appropriate confidentiality designations.
This communication is intended solely for the use of the addressee(s) and may contain information that is privileged, confidential, and exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, please notify the sender immediately and destroy all copies.
Fund | Aggregate Overvaluation
Ironside Credit Opportunities Fund LP (Fund I) | $156.4 million
Ironside Structured Alpha Fund LP (Fund II) | $88.7 million
Ironside Special Situations Fund LP (Fund III) | $41.9 million
Total | $287.0 million

CALDERWOOD & HARKNESS LLP

Record

Parties

Dates

Amounts